Cargando…
Learn–confirm in model‐informed drug development: Assessing an immunogenicity quantitative systems pharmacology platform
Immunogenicity against therapeutic proteins frequently causes attrition owing to its potential impact on pharmacokinetics, pharmacodynamics, efficacy, and safety. Predicting immunogenicity is complex because of its multifactorial drivers, including compound properties, subject characteristics, and t...
Autores principales: | Franssen, Linnea C., Swat, Maciej J., Kierzek, Andrzej M., Rose, Rachel H., van der Graaf, Piet H., Grimm, Hans Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931426/ https://www.ncbi.nlm.nih.gov/pubmed/36418887 http://dx.doi.org/10.1002/psp4.12887 |
Ejemplares similares
-
Application of quantitative systems pharmacology to guide the optimal dosing of COVID‐19 vaccines
por: Giorgi, Mario, et al.
Publicado: (2021) -
A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins
por: Kierzek, Andrzej M., et al.
Publicado: (2019) -
Immunogenicity in Clinical Practice and Drug Development: When is it Significant?
por: Shakhnovich, Valentina, et al.
Publicado: (2019) -
Model‐informed target identification and validation through combining quantitative systems pharmacology with network‐based analysis
por: Chelliah, Vijayalakshmi, et al.
Publicado: (2022) -
A Quantitative Systems Pharmacology Perspective on the Importance of Parameter Identifiability
por: Sher, Anna, et al.
Publicado: (2022)